PE / VC
2018
$2 500 M
New York City, New York, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Hildred Capital is a New York based private equity firm focusing on the healthcare industry. Hildred pursues growth equity investments in lower middle market healthcare companies located in the U.S. and Canada with leading products, technologies and services. Hildred seeks opportunities to create value in healthcare companies with revenues of up to $100 million, from scaling businesses to generate earnings growth, promoting strategic and operational improvements, generating business development, and driving multiple expansion.
Industry
Region of investment
Hildred Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Hildred Equity Partners III
|
Private Equity (PE)
|
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$800 M
|
January 2025
|
|
Hildred Equity Partners II
|
Private Equity (PE)
|
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$363 M
|
February 2022
|